1.3 Proactive Analysis: Failure Modes and Effects Analysis

The Principles of Proactive Risk Assessment

While reactive tools like Root Cause Analysis focus on investigating past failures, proactive risk assessment seeks to identify and mitigate vulnerabilities before they result in harm. The primary framework used in healthcare for proactive assessment is Failure Modes and Effects Analysis (FMEA). FMEA is a systematic, team-based, prospective method used to analyze a clinical or administrative process to determine where and how it might fail, calculate the potential impact of those failures, and design process-level safeguards. In contrast to retrospective reviews, FMEA assumes that errors are inevitable and seeks to design systems that make errors visible or harmless. The Joint Commission mandates that accredited healthcare organizations perform at least one proactive risk assessment (such as FMEA) annually on a high-risk clinical process (e.g., pediatric medication administration, specimen labeling, or blood transfusion).

Core Terminology of FMEA

To execute an FMEA successfully, safety professionals must understand its core terms:

• Process Steps: The individual, sequential actions that make up a clinical workflow (e.g., prescribing, transcribing, dispensing, administering).
• Failure Mode: What could go wrong at a specific step in the process (e.g., wrong patient selected, wrong dose entered, barcode bypassed).
• Failure Effect: The clinical consequence of the failure mode on the patient or system (e.g., severe hypoglycemia, medication toxicity, delayed care).
• Root Cause: The underlying system-level reason why the failure mode would occur (e.g., identical packaging, poor screen contrast, inadequate training).

Calculating the Risk Priority Number (RPN)

The FMEA team evaluates each identified failure mode along three dimensions using a 1-to-10 scoring scale. The product of these scores determines the Risk Priority Number (RPN), which is used to prioritize which failure modes require immediate mitigation.

The formula is: $\text{RPN} = \text{Severity} \times \text{Occurrence} \times \text{Detection}$

Each dimension is defined as follows:

1. Severity (S): The seriousness of the effect on the patient if the failure mode occurs. A score of 1 indicates no clinical effect; a score of 10 indicates catastrophic harm or patient death.
2. Occurrence (O): The probability or frequency that the failure mode will occur, based on historical data or team consensus. A score of 1 indicates the failure is extremely remote; a score of 10 indicates the failure is virtually inevitable.
3. Detection (D): The likelihood that the failure mode will be detected before it reaches the patient. Note that this scale is inverse: a score of 1 indicates detection is almost certain (low risk, high safeguard visibility); a score of 10 indicates detection is highly unlikely or impossible (high risk, no safeguards present).

$RPN \text{ range: } 1 \text{ (lowest risk) to } 1000 \text{ (highest risk).}$

While FMEA teams generally prioritize failure modes with the highest RPNs, they must also prioritize any failure mode with a high Severity score (e.g., 9 or 10) regardless of its final RPN. This ensures that potentially catastrophic events are mitigated even if they are extremely rare.

FMEA Team Composition

FMEA is a collaborative tool that cannot be performed by a single manager in an office. To capture the difference between work-as-imagined (how policies say work should be done) and work-as-done (how frontline staff actually perform the work), the team must be multidisciplinary. The team must include:

• Frontline staff who execute the process steps daily (nurses, pharmacists, technicians). These individuals understand the workarounds, friction points, and unwritten rules that keep the system running.
• Process owners or managers who have the authority to change workflows and allocate resources.
• A facilitator trained in FMEA methodology (usually a patient safety officer) to guide the scoring and mapping process.
• Content experts (such as information technology professionals, risk managers, or clinical specialists) when relevant.

The FMEA process begins with a detailed mapping of the chosen workflow. The team constructs a detailed process flowchart to break the overall process down into small, digestible steps. Often, teams use a swimlane diagram to show which clinician or department is responsible for each step. After mapping the current process, the team systematically brainstorms potential failure modes for each step before applying the scoring criteria.

Sample FMEA Matrix

The table below illustrates a simplified FMEA matrix for a medication administration process, showing how RPNs are calculated and used to guide recommended actions.

Designing Proactive Safeguards

Once high-RPN failure modes are identified, the team must propose system redesigns. Redesigns should target the elements of the RPN calculation:

• Reducing Severity: Often difficult, but can be achieved by limiting doses (e.g., maximum vial sizes or smart-pump limits).
• Reducing Occurrence: Eliminating the step, automating the process, or standardizing equipment to prevent the error from happening.
• Improving Detection: Introducing checks (e.g., barcode scans or double-signature requirements) that make the error visible before the patient is reached.